Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.
The team hope the compound –developed after 10 years of painstaking research will be trialled on humans within three to four years.
The drug- which works by targeting Mycobacterium tuberculosis’ defences rather than the bacteria itself – can also take out its increasingly commonly antibiotic resistant strains.
The research funded by the Medical Research Council – is published today in the Journal of Medicinal Chemistry.
Although a vaccine for TB was developed 100 years ago, one in three people across the world are thought to be infected with the infectious disease.
About 1.7 million die from the bug each year worldwide and 7.3 million people were diagnosed and treated in 2018, up from the 6.3 million in 2016.
It is most common in Africa, India and China, but on the rise in the UK with London often described as the TB capital of Europe.
Patients are forced to take a cocktail of strong antibiotics over 6 to 8 months, often enduring unpleasant side effects with a 20% risk that the disease will return.
But now The University of Manchester team’s discovery has been proven effective in guinea pigs at Rutgers University in the United States.
The animals with acute and chronic TB infection were treated with the compound, which was discovered after investigating dozens of other derivatives and compounds thought to have similar properties.
Professor Lydia Tabernero is the project leader. She said: “The fact that the animal studies showed our compound, which doesn’t kill the bacteria directly, resulted in a significant reduction in the bacterial burden is remarkable.
“For more than 60 years, the only weapon doctors have been able to use against TB is antibiotics. But resistance is becoming an increasingly worrying problem and the prolonged treatment is difficult and distressing for patients.
“And with current treatments, there’s no guarantee the disease will be eliminated: antibiotics do not clear the infection and the risk of being infected with drug-resistant bacteria is very high.
“But by disabling this clandestine bacteria’s defences we’re thrilled to find a way that enhances the chances of the body’s immune system to do its job, and thus eliminate the pathogen.”
Mycobacterium Tuberculosis secretes molecules called Virulence Factors – the cell’s secret weapon -which block out the immune response to the infection, making it difficult to treat.
The team identified one Virulence Factor called MptpB as a suitable target, which when blocked allows white blood cells to kill Mycobacterium Tuberculosis in a more efficient way
Professor Tabernero added: “The great thing about MptpB is that there’s nothing similar in humans – so our compound which blocks it is not toxic to the human cells.
“Because the bacteria hasn’t been threatened directly, it is less likely to develop resistance against this new agent, and this will be a major advantage over current antibiotics, for which bacteria had already become resistant.
“TB is an amazingly difficult disease to treat so we feel this is a significant breakthrough.
”The next stage of our research is to optimise further the chemical compound, but we hope clinical trials are up to four years away.”
Learn more: Scientists develop new drug treatment for TB
Receive an email update when we add a new TUBERCULOSIS article.
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
Global conference on tuberculosis in India next year
on November 21, 2018 at 7:25 am
New Delhi: The International Union against Tuberculosis (TB) and Lung Diseases will convene its 50th Union World conference on lung health in Hyderabad next year, a move that will give impetus to the ... […]
There is great news on tuberculosis, but action is still needed
on November 20, 2018 at 11:43 am
The world’s deadliest infectious killer disease finally had its day. On Sept. 26, 2018, world leaders pledged to reach 40 million people with tuberculosis treatment at the United Nations’ first high-l... […]
Tuberculosis Treatment Drugs Market Incredible Possibilities, Growth Analysis and Forecast To 2023
on November 20, 2018 at 9:38 am
The Tuberculosis Treatment Drugs market dynamics, forces, companies and trends have been determined after conducting a detailed study of the industry for this newly released research report now availa... […]
Migrant Rescue Ship Must Be Seized to Prevent Spread of HIV, Scabies, Tuberculosis: Prosecutors
on November 20, 2018 at 8:37 am
Italian authorities have ordered the seizure of a migrant rescue ship and launched an investigation into its operators over claims of mismanagement of waste, including clothing they reportedly claim c... […]
Bovine tuberculosis identified in B.C. cow, but officials say no risk to humans
on November 20, 2018 at 7:54 am
VANCOUVER—A cow from a farm in British Columbia’s southern Interior has tested positive for bovine tuberculosis but the Canadian Food Inspection Agency says there is no risk to human health or the foo... […]
Eugene Bell proposes setting up national tuberculosis laboratory at KIC
on November 19, 2018 at 7:00 pm
The Eugene Bell Foundation on Friday proposed the establishment of a national tuberculosis laboratory at the now-shuttered Kaesong Industrial Complex (KIC). In comments following the NGO’s head Stephe... […]
Steer that tested positive for bovine tuberculosis traced to Potter County seller
on November 19, 2018 at 12:19 pm
Animal health officials believe that a steer that tested positive for bovine tuberculosis was at a feedlot in Potter County before it was sold to DemKota Ranch Beef for slaughter. State Veterinarian D... […]
2PG Company receives grant to develop sensitive, low-cost molecular diagnostic tests for tuberculosis
on November 19, 2018 at 5:36 am
Two Pore Guys, Inc. (2PG) today announced that the company has received a $2.8 million grant from the Bill & Melinda Gates Foundation to develop sensitive, low-cost molecular diagnostic tests for tube... […]
Red Dead Redemption 2: Can You Cure Tuberculosis?
on November 17, 2018 at 10:08 am
While tuberculosis-related deaths in the United States are virtually non-existent in this day and age, the disease still regularly claims over 1 million lives per year in other parts of the world ... […]
via Bing News